Cheminformatics in natural product‐based drug discovery
This review seeks to provide a timely survey of the scope and limitations of cheminformatics
methods in natural product‐based drug discovery. Following an overview of data resources …
methods in natural product‐based drug discovery. Following an overview of data resources …
Advances in the development of shape similarity methods and their application in drug discovery
A Kumar, KYJ Zhang - Frontiers in chemistry, 2018 - frontiersin.org
Molecular similarity is a key concept in drug discovery. It is based on the assumption that
structurally similar molecules frequently have similar properties. Assessment of similarity …
structurally similar molecules frequently have similar properties. Assessment of similarity …
SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
A Daina, O Michielin, V Zoete - Nucleic acids research, 2019 - academic.oup.com
SwissTargetPrediction is a web tool, on-line since 2014, that aims to predict the most
probable protein targets of small molecules. Predictions are based on the similarity principle …
probable protein targets of small molecules. Predictions are based on the similarity principle …
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
Bioactive small molecules, such as drugs or metabolites, bind to proteins or other macro-
molecular targets to modulate their activity, which in turn results in the observed phenotypic …
molecular targets to modulate their activity, which in turn results in the observed phenotypic …
SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening
SwissSimilarity is a new web tool for rapid ligand-based virtual screening of small to
unprecedented ultralarge libraries of small molecules. Screenable compounds include …
unprecedented ultralarge libraries of small molecules. Screenable compounds include …
Toward more realistic drug–target interaction predictions
A number of supervised machine learning models have recently been introduced for the
prediction of drug–target interactions based on chemical structure and genomic sequence …
prediction of drug–target interactions based on chemical structure and genomic sequence …
Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis
We carried out a systematic evaluation of target selectivity profiles across three recent large-
scale biochemical assays of kinase inhibitors and further compared these standardized …
scale biochemical assays of kinase inhibitors and further compared these standardized …
Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms
Y Wan, L Xu, Z Liu, M Yang, X Jiang, Q Zhang… - … and alternative medicine, 2019 - Springer
Abstract Background Wumei Pill (WMP), a famous herbal formula, has been widely used to
treat digestive system diseases in clinical practice in China for centuries. We have found a …
treat digestive system diseases in clinical practice in China for centuries. We have found a …
First Insight into the Formation of In Vivo Transformation Products of 2-Ethylhexyl diphenyl phosphate in Zebrafish and Prediction of Their Potential Toxicities
R Yang, Y Ye, Y Chen, Y Yang, L Yang… - Environmental …, 2022 - ACS Publications
As a frequently detected organophosphorus flame retardant in the environment, 2-ethylhexyl
diphenyl phosphate (EHDPHP) is vulnerable to biotransformation, while the transformation …
diphenyl phosphate (EHDPHP) is vulnerable to biotransformation, while the transformation …
Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: A bioinformatics approach
RP Leão, JV Cruz, GV da Costa, JN Cruz… - Pharmaceuticals, 2020 - mdpi.com
The cyclooxygenase-2 receptor is a therapeutic target for planning potential drugs with anti-
inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was …
inflammatory activity. The selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib was …